My watch list
my.bionity.com  
Login  
NEWS
Current news

GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

ANTABIO Completes € 12.5M Series A financing

13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

A cost-effective way to produce ‘green’ bioherbicide

13-Jul-2018 Here’s some good news for conventional and organic farmers alike: Researchers at theUniversity of Florida College of Pharmacy have discovered a way to cost-effectively produce the bioherbicide thaxtomins. This means organic farmers can use the natural chemicals to ward off weeds and convent ... more

Less failure in CRIPSR gene editing

Biochemists discover cause of genome editing failures

13-Jul-2018 Researchers from the University of Illinois at Chicago are the first to describe why CRISPR gene editing sometimes fails to work, and how the process can be made to be much more efficient. CRISPR is a gene-editing tool that allows scientists to cut out unwanted genes or genetic material fro ... more

Measuring the Effects of Drugs on Cancer Cells

13-Jul-2018 A new approach established at the University of Zurich sheds light on the effects of anti-cancer drugs and the defense mechanisms of cancer cells. The method makes it possible to quickly test various drugs and treatment combinations at the cellular level. Cancer cells are cells over which t ... more

EXIST Grant support for "Tetra-Tag" start-up

New tetrazines with improved characteristics

13-Jul-2018 Germany's Federal Ministry for Economic Affairs and Energy (BMWi), the European Social Fund (ESF) and the European Union (EU) are funding the start-up venture "Tetra-Tag" with an EXIST Business Start-up Grant. Two chemists, Dr. Fabian Ehret and Dr. Vasileios Filippou, and the economist Patr ... more

New informatics tool makes the most of genomic data

13-Jul-2018 The rise of genomics, the shift from considering genes singly to collectively, is adding a new dimension to medical care; biomedical researchers hope to use the information contained in human genomes to make better predictions about individual health, including responses to therapeutic drug ... more

Can nanoparticles be used to lower antibiotic resistance?

13-Jul-2018 Antibiotic resistance is one of the world's most serious threats to public health, forcing the use of medications that are more toxic, more expensive and not always effective. There are several causes, including over-prescription of antibiotics in both humans and in livestock. Two engineers ... more

An ATM that dispenses antioxidants

Dual role of protein that watches for cellular threats and repairs damage

12-Jul-2018 One reason we're supposed to eat a variety of colorful fruits and vegetables is because they contain nutritious compounds called antioxidants. These molecules counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research led by ... more

All news

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

Measuring the Effects of Drugs on Cancer Cells

13-Jul-2018 A new approach established at the University of Zurich sheds light on the effects of anti-cancer drugs and the defense mechanisms of cancer cells. The method makes it possible to quickly test various drugs and treatment combinations at the cellular level. Cancer cells are cells over which t ... more

New informatics tool makes the most of genomic data

13-Jul-2018 The rise of genomics, the shift from considering genes singly to collectively, is adding a new dimension to medical care; biomedical researchers hope to use the information contained in human genomes to make better predictions about individual health, including responses to therapeutic drug ... more

Therapeutic Antibodies Show Variations

Subtle Differences: Therapeutic Antibodies Vary Depending on Production System

11-Jul-2018 Differences in production methods for therapeutic antibodies can lead to variations in their structure, depending on the recombinant procedure selected. The distinctions, which are based on a number of glycosylations, even impact antibodies’ stability. This was the result of a high-precisio ... more

New targets found to reduce blood vessel damage in diabetes

09-Jul-2018 In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature. Now scientists have evidence that these breakups occur as another relationship falls apart. ... more

How herpesviruses escape from the immune system

06-Jul-2018 Herpesviruses are the cause of many diseases, such as shingles or mononucleosis ('kissing disease') that compromise our quality of life. While the human immune system can usually prevent the spread of herpesviruses, it cannot entirely eliminate them from our bodies. This is because these vi ... more

New insight into the maturation of miRNAs

04-Jul-2018 An international research team led by Helmholtz Zentrum München, Technical University of Munich and the University of Edinburgh has used an integrated structural biological approach to elucidate the maturation of a cancer-causing microRNA in gene regulation. In the future, the authors hope ... more

Bacteria can 'divide and conquer' to vanquish their enemies

04-Jul-2018 Some bacteria can release toxins that provoke their neighbours into attacking each other, a tactic that could be exploited to fight infections. Bacteria often engage in 'warfare' by releasing toxins or other molecules that damage or kill competing strains. This war for resources occurs in m ... more

Gene discovery unlocks mysteries to our immunity

02-Jul-2018 Australia's national science agency CSIRO has identified a new gene that plays a critical role in regulating the body's immune response to infection and disease. The discovery could lead to the development of new treatments for influenza, arthritis and even cancer. The gene, called C6orf106 ... more

Structure of S. agalactiae toxin identified

29-Jun-2018 Streptococcus (S.) agalactiae (contains the CAMP factor) is a round bacterium that could cause severe invasive infections. Biologists team led by Prof. JIN Tengchuan from University of Science and Technology of China of Chinese Academy of Sciences and Dr. Eric Brefo-Mensah from the Universi ... more

All news on bioanalytics

GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

ANTABIO Completes € 12.5M Series A financing

13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

A cost-effective way to produce ‘green’ bioherbicide

13-Jul-2018 Here’s some good news for conventional and organic farmers alike: Researchers at theUniversity of Florida College of Pharmacy have discovered a way to cost-effectively produce the bioherbicide thaxtomins. This means organic farmers can use the natural chemicals to ward off weeds and convent ... more

Less failure in CRIPSR gene editing

Biochemists discover cause of genome editing failures

13-Jul-2018 Researchers from the University of Illinois at Chicago are the first to describe why CRISPR gene editing sometimes fails to work, and how the process can be made to be much more efficient. CRISPR is a gene-editing tool that allows scientists to cut out unwanted genes or genetic material fro ... more

New informatics tool makes the most of genomic data

13-Jul-2018 The rise of genomics, the shift from considering genes singly to collectively, is adding a new dimension to medical care; biomedical researchers hope to use the information contained in human genomes to make better predictions about individual health, including responses to therapeutic drug ... more

Can nanoparticles be used to lower antibiotic resistance?

13-Jul-2018 Antibiotic resistance is one of the world's most serious threats to public health, forcing the use of medications that are more toxic, more expensive and not always effective. There are several causes, including over-prescription of antibiotics in both humans and in livestock. Two engineers ... more

An ATM that dispenses antioxidants

Dual role of protein that watches for cellular threats and repairs damage

12-Jul-2018 One reason we're supposed to eat a variety of colorful fruits and vegetables is because they contain nutritious compounds called antioxidants. These molecules counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research led by ... more

Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

12-Jul-2018 Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gy ... more

Immune cells can switch from ‘gang members’ to ‘police officers’

12-Jul-2018 When the immune system overreacts, as in an allergic reaction, cells causing trouble can change into cells that dampen the reaction. Learning to control the mechanism behind the switch could be used to make more effective immunotherapies, say the authors of the new study, led by Imperial Co ... more

Focussed ultrasound used to improve effects of cancer drugs

12-Jul-2018 Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to imp ... more

All news on biotechnology

A first look at interstitial fluid flow in the brain

05-Jul-2018 Interstitial fluid transports nutrients and removes waste between the organs and tissues in our body. In the brain, interstitial fluid is thought to be composed of circulating cerebrospinal fluid, cellular waste and blood plasma, and past research has shown a link between interstitial fluid ... more

Aptamer Group raises $2.2M investment

02-Jul-2018 Rapidly growing biotech business,Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme. The funding will enable the expansion of the York ... more

Your brain with a migraine

28-Jun-2018 When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine. When researchers see the brain image of an aura, they try to figure out what causes it and if there is a way to stop the start of the migraine. Now an int ... more

Beer. Soup. Barley's next great use? A medical imaging drink

28-Jun-2018 Before launching their latest science experiment, University at Buffalo researchers bought more than 200 types of tea, chocolate, herbs and other foodstuffs. The goal wasn't to stock up for long hours in the lab, but rather to find an elusive, edible contrast agent to show doctors what's ha ... more

Low-cost plastic sensors could monitor a range of health conditions

27-Jun-2018 An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases. The sensor can measure the amount of critical metab ... more

Bruker acquires Hamburg-based sensor start-up

27-Jun-2018 Thanks to its innovative, patented sensor technologies, a portfolio company in the High-Tech Gründerfond (HTGF) has reached market maturity: USA’s Bruker Corporation has taken over Hamburg startup Sierra Sensors GmbH. Sierra Sensors develop and distribute biosensor-based analytical tools an ... more

A sprinkle of platinum nanoparticles onto graphene makes brain probes more sensitive

18-Jun-2018 Graphene electrodes could enable higher quality imaging of brain cell activity thanks to new research by a team of engineers and neuroscientists at the University of California San Diego. The researchers developed a technique, using platinum nanoparticles, to lower the impedance of graphene ... more

Automated robotic device for faster blood testing developed

14-Jun-2018 Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients. "This device represents ... more

Contaminated lab kits

Scientific sleuthing for reproducible results

14-Jun-2018 Researchers found traces of foreign, non-human genetic material in human blood samples. It turned out that it was not a groundbreaking scientific discovery, but mostly the result of contaminated laboratory materials. Scientists led by Associate Prof. Paul Wilmes of the Luxembourg Centre for ... more

Making data matter

A multimaterial, voxel-printing method turns imaging datasets into physical objects

13-Jun-2018 The world is awash in digital images, from photographs to x-rays to computer models to 3D scans. The advent of 3D printing has made it possible to take imaging data and print it into physical representations, but the process of doing so has been prohibitively time-intensive and costly. A ne ... more

All news on diagnostics

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

Bruker acquires Hamburg-based sensor start-up

27-Jun-2018 Thanks to its innovative, patented sensor technologies, a portfolio company in the High-Tech Gründerfond (HTGF) has reached market maturity: USA’s Bruker Corporation has taken over Hamburg startup Sierra Sensors GmbH. Sierra Sensors develop and distribute biosensor-based analytical tools an ... more

Labstep raises £1 Million to launch marketplace and double its team

Users growing 15% month on month with a 95% retention rate

26-Jun-2018 Labstep, the platform for researchers that captures real-time scientific data and connects lab groups enabling information sharing and reproducibility, announces today that it has raised £1 Million from angel investors. The company will use the funds to double its team to 12, launch a marke ... more

Change at the top at Greiner Bio-One GmbH

21-Jun-2018 Jakob Breuer (51) has become the new Chief Technology Officer (CTO) of the Greiner Bio-One BioScience division in Frickenhausen. Breuer, an engineering graduate, was appointed to the post in April 2018, taking over from Rudi Vollmer, who is retiring after over 40 successful years at the com ... more

LABVOLUTION 2019: Spotlight on the integrated laboratory

21-Jun-2018 Modern laboratory practice is a fast-changing area characterized by growing digitization, automation, ever more complex workflows, and interaction at all levels. The next LABVOLUTION show is picking up on these trends with a strong focus on digital integration and connectivity, as evidenced ... more

New DNA synthesis technique promises rapid, high-fidelity DNA printing

20-Jun-2018 Scientists at the University of California, Berkeley, and Lawrence Berkeley National Laboratory have invented a new way to synthesize DNA that promises to be easier and faster, does not require the use of toxic chemicals and is potentially more accurate. With greater accuracy, the technique ... more

Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation

Siemens becomes a preferred supplier for automation solutions

14-Jun-2018 The Siemens technology group andSartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim Biotech will preferably use Siemens automation t ... more

Reaction calorimetry in microreactors

12-Jun-2018 At Achema 2018 the Fraunhofer Institute for Chemical Technology will demonstrate the latest gen-eration of continuous reaction calorimeters. These permit rapid screening of thermokinetic data, making kinetic constants and safety-relevant data available in the early stages of process develop ... more

Self-sustaining loop of chemical reactions could revolutionize drug production

07-Jun-2018 Experts from the University of Nottingham have created a self-sustaining circuit of reactions which is a greener and more efficient method of chemical production. Drs Francesca Paradisi and Martina Contente of the University of Nottingham produce chemicals more efficiently through a looped ... more

ChemMaps lets researchers navigate the chemical universe

06-Jun-2018 Researchers from North Carolina State University have created a new online service - ChemMaps - that allows users to interactively navigate the chemical space of over 8,000 drugs and 47,000 environmental compounds in 3D and real time. ChemMaps is designed to be a central resource for studen ... more

All news on lab technology

ANTABIO Completes € 12.5M Series A financing

13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

EXIST Grant support for "Tetra-Tag" start-up

New tetrazines with improved characteristics

13-Jul-2018 Germany's Federal Ministry for Economic Affairs and Energy (BMWi), the European Social Fund (ESF) and the European Union (EU) are funding the start-up venture "Tetra-Tag" with an EXIST Business Start-up Grant. Two chemists, Dr. Fabian Ehret and Dr. Vasileios Filippou, and the economist Patr ... more

Can nanoparticles be used to lower antibiotic resistance?

13-Jul-2018 Antibiotic resistance is one of the world's most serious threats to public health, forcing the use of medications that are more toxic, more expensive and not always effective. There are several causes, including over-prescription of antibiotics in both humans and in livestock. Two engineers ... more

An ATM that dispenses antioxidants

Dual role of protein that watches for cellular threats and repairs damage

12-Jul-2018 One reason we're supposed to eat a variety of colorful fruits and vegetables is because they contain nutritious compounds called antioxidants. These molecules counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research led by ... more

Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

12-Jul-2018 Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gy ... more

Focussed ultrasound used to improve effects of cancer drugs

12-Jul-2018 Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to imp ... more

ProBioGen and Pionyr Immunotherapeutics initiate second collaboration

Collaboration in contract development and manufacturing

11-Jul-2018 ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, andPionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor microenvironment, today announced a second service and lic ... more

Evolva announces new CEO

11-Jul-2018 Evolva announces that as part of entering the next phase of its evolution, the current Evolva CEO Simon Waddington steps down as CEO with immediate effect. Until he will leave the company towards the end of 2018, he will support the new CEO in completing work on Evolva’s technology base. Th ... more

Artificial intelligence helps Stanford researchers predict drug combinations' side effects

11-Jul-2018 Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades. And if that isn't surprising enough, try this one: in many cases, doc ... more

CO.DON negotiates with Xintela on the establishment of a joint venture

10-Jul-2018 CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of stem cell based options for the treatment of cartilage disor ... more

All news on pharma

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

ANTABIO Completes € 12.5M Series A financing

13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

Less failure in CRIPSR gene editing

Biochemists discover cause of genome editing failures

13-Jul-2018 Researchers from the University of Illinois at Chicago are the first to describe why CRISPR gene editing sometimes fails to work, and how the process can be made to be much more efficient. CRISPR is a gene-editing tool that allows scientists to cut out unwanted genes or genetic material fro ... more

Measuring the Effects of Drugs on Cancer Cells

13-Jul-2018 A new approach established at the University of Zurich sheds light on the effects of anti-cancer drugs and the defense mechanisms of cancer cells. The method makes it possible to quickly test various drugs and treatment combinations at the cellular level. Cancer cells are cells over which t ... more

Can nanoparticles be used to lower antibiotic resistance?

13-Jul-2018 Antibiotic resistance is one of the world's most serious threats to public health, forcing the use of medications that are more toxic, more expensive and not always effective. There are several causes, including over-prescription of antibiotics in both humans and in livestock. Two engineers ... more

An ATM that dispenses antioxidants

Dual role of protein that watches for cellular threats and repairs damage

12-Jul-2018 One reason we're supposed to eat a variety of colorful fruits and vegetables is because they contain nutritious compounds called antioxidants. These molecules counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research led by ... more

Immune cells can switch from ‘gang members’ to ‘police officers’

12-Jul-2018 When the immune system overreacts, as in an allergic reaction, cells causing trouble can change into cells that dampen the reaction. Learning to control the mechanism behind the switch could be used to make more effective immunotherapies, say the authors of the new study, led by Imperial Co ... more

Focussed ultrasound used to improve effects of cancer drugs

12-Jul-2018 Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to imp ... more

How a Mediterranean diet could reduce osteoporosis

11-Jul-2018 Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis - according to new research from the University of East Anglia. New findings published today show that sticking to a diet rich in fruit, vegetables, nuts, unrefined cereals, olive oil, and fish can reduce hi ... more

ProBioGen and Pionyr Immunotherapeutics initiate second collaboration

Collaboration in contract development and manufacturing

11-Jul-2018 ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, andPionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor microenvironment, today announced a second service and lic ... more

All news on healthcare
News by department
  • Products

    EXIST Grant support for "Tetra-Tag" start-up

    New tetrazines with improved characteristics

    13-Jul-2018 Germany's Federal Ministry for Economic Affairs and Energy (BMWi), the European Social Fund (ESF) and the European Union (EU) are funding the start-up venture "Tetra-Tag" with an EXIST Business Start-up Grant. Two chemists, Dr. Fabian Ehret and Dr. Vasileios Filippou, and the economist Patr ... more

    Evotec receives € 3 million payment from Sanofi

    Evotec achieves second milestone in diabetes alliance with Sanofi

    26-Jun-2018 Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of € 3 million to Evotec.  This milestone was triggered after Evotec met pre-agreed critical success criteria for a pot ... more

    Prellis Biologics achieves milestone in 3D printing of human tissue with capillaries

    25-Jun-2018 Prellis Biologics , a San Francisco-based 3D tissue printing company, announced that it has reached record speed and resolution in the quest to print human tissue with viable capillaries, bringing the goal of printing human replacement organs closer to reality. "A major goal in tissue engin ... more

  • Business

    GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

    13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

    New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

    13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

    EXIST Grant support for "Tetra-Tag" start-up

    New tetrazines with improved characteristics

    13-Jul-2018 Germany's Federal Ministry for Economic Affairs and Energy (BMWi), the European Social Fund (ESF) and the European Union (EU) are funding the start-up venture "Tetra-Tag" with an EXIST Business Start-up Grant. Two chemists, Dr. Fabian Ehret and Dr. Vasileios Filippou, and the economist Patr ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

    13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

    ANTABIO Completes € 12.5M Series A financing

    13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

    A cost-effective way to produce ‘green’ bioherbicide

    13-Jul-2018 Here’s some good news for conventional and organic farmers alike: Researchers at theUniversity of Florida College of Pharmacy have discovered a way to cost-effectively produce the bioherbicide thaxtomins. This means organic farmers can use the natural chemicals to ward off weeds and convent ... more

  • People

    New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

    13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

    Evolva announces new CEO

    11-Jul-2018 Evolva announces that as part of entering the next phase of its evolution, the current Evolva CEO Simon Waddington steps down as CEO with immediate effect. Until he will leave the company towards the end of 2018, he will support the new CEO in completing work on Evolva’s technology base. Th ... more

    This year’s research prize awarded by Eppendorf AG goes to Switzerland

    2018 Eppendorf Award for Young European Investigators presented to Andrea Ablasser

    27-Jun-2018 In 2018, the Hamburg life science company is presenting its research prize for the 23rd time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Andrea Ablasser, Assistant Professor at the Swiss Federal Institute of Technology, Lausanne, Switzerland, as t ... more

  • Finances

    GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

    13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

    ANTABIO Completes € 12.5M Series A financing

    13-Jul-2018 Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an additional €5.2 million subscribed by investment funds Omnes, BNP Paribas Développement, and Sham Innovati ... more

    ProBioGen and Pionyr Immunotherapeutics initiate second collaboration

    Collaboration in contract development and manufacturing

    11-Jul-2018 ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, andPionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor microenvironment, today announced a second service and lic ... more

  • Cooperation

    GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

    13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

    Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

    12-Jul-2018 Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gy ... more

    ProBioGen and Pionyr Immunotherapeutics initiate second collaboration

    Collaboration in contract development and manufacturing

    11-Jul-2018 ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, andPionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor microenvironment, today announced a second service and lic ... more

  • Technology

    GLOBAL BIOENERGIES and AUDI continue partnership in renewable gasoline

    13-Jul-2018 Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program. The first focus will be the regulatory landscape associated with the conversion of various non-food residue f ... more

    A cost-effective way to produce ‘green’ bioherbicide

    13-Jul-2018 Here’s some good news for conventional and organic farmers alike: Researchers at theUniversity of Florida College of Pharmacy have discovered a way to cost-effectively produce the bioherbicide thaxtomins. This means organic farmers can use the natural chemicals to ward off weeds and convent ... more

    Less failure in CRIPSR gene editing

    Biochemists discover cause of genome editing failures

    13-Jul-2018 Researchers from the University of Illinois at Chicago are the first to describe why CRISPR gene editing sometimes fails to work, and how the process can be made to be much more efficient. CRISPR is a gene-editing tool that allows scientists to cut out unwanted genes or genetic material fro ... more

  • Laws

    Combined resistance to multiple antibiotics: A growing problem in the EU

    17-Nov-2017 On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance, as well as its guidance on prevention and control of carbapenem-resistant Enterobacteriaceae (CRE). In ... more

    Focus on Medical Device Regulation

    BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

    15-Nov-2017 The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterpri ... more

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    04-Aug-2017 Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

  • Market

    Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

    19-Jun-2018 Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ... more

    Recipharm invests in Brexit preparations

    25-May-2018 Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. With less than a year until the UK exits the European Union (EU), the Sweden headquartered global CDMO is focused on managing the transition with minimal impact to its operations an ... more

    Gerresheimer expands production of pharmaceutical plastic packaging in Brazil

    23-May-2018 Gerresheimer, the leading manufacturer of specialist packaging for drugs, is further expanding its strong presence on the South American market. The new Gerresheimer Anápolis plant has commenced production in the Brazilian state of Goiás in order to secure and support the continued strong g ... more

  • Politics

    Multinational companies continue to produce unregulated antibiotics in India

    06-Feb-2018 Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University. The research found that multinational companies continued to manufacture many unapproved formulations, despite pledging to tackle ... more

    cytena receives Dr. Rudolf-Eberle-Prize 2017

    Ministry of Economics recognizes cytena’s innovative energy

    01-Dec-2017 cytena was distinguished with the Innovation Award of Baden-Württemberg, one of the most economically powerful and competitive regions in Europe. Since 1985, the Ministry of Economics recognizes small and medium-sized enterprises for their innovative products, processes and services. The Mi ... more

    EMA to relocate to Amsterdam

    Working with Dutch government to ensure successful move by end of March 2019

    22-Nov-2017 The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands. This decision was taken today by the EU 27 Member States in the margins of the General Affairs Council (Art.50). The Agency now has just over 16 months to prepare for the move and take up its operations in Am ... more

  • Manufacturing

    BASF lifts force majeure for key vitamin A and E products

    03-Jul-2018 BASF lifts force majeure for Lutavit® A 1000, Lutavit® A 500, Vitamin A Palmitate 1.6 Mio I.U./g, Lutavit® E 50, Lutavit® E 50 S, and Vitamin E Acetate 94% products for its animal nutrition business. The lifting of force majeure for additional vitamin derivatives and for several affected ca ... more

    Biological processing of precious metal ores

    BRAIN AG and CyPlus GmbH develop disruptive technologies

    25-Jun-2018 The bioeconomy company BRAIN AG and CyPlus GmbH have announced the development of an initial range of market-relevant products for the global mining industry. This work has been carried out as part of a multi-year collaboration between the companies in the area of biological ore processing ... more

    Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

    19-Jun-2018 Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ... more

  • Career

    Agilent and University of Duisburg-Essen Announce Collaboration Agreement

    New Teaching and Research Center for Separation

    28-May-2018 Agilent Technologies Inc. and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent's leading analytical technologies with the University's outstanding researchers. As part of the collaboration, Agilent will support the university with a broad ra ... more

    Systematic analysis of data from animal models reveals opportunities and limitations

    Professor Malcolm Macleod awarded the BfR’s Maria Sibylla Merian Fellowship

    18-Apr-2018 What opportunities and what limits result from the use of laboratory animals in the preclinical and clinical research? Neurologist Malcolm Macleod has dedicated himself to this topic. For his interdisciplinary research work and his contribution to improving animal welfare, he is awarded thi ... more

    Sartorius Stedim supports biotech training at U Penn

    17-Apr-2018 Sartorius Stedim Biotech andPenn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part o ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE